{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:32:54Z","timestamp":1777264374817,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This project was partially funded by F003\/CECIHTI","award":["840801"],"award-info":[{"award-number":["840801"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11064-026-04716-8","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:33:56Z","timestamp":1772703236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidepressant-like effect of hydroxytyrosol in a 1-methyl-4-phenylpyridinium model of Parkinson\u2019s disease in rats"],"prefix":"10.1007","volume":"51","author":[{"given":"Gabriela","family":"P\u00e9rez-Barr\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia L.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"L\u00f3pez-Rubalcava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Garc\u00eda-Esparza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Monroy-Noyola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"4716_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s Disease and Parkinsonism. Am J Med 132:802\u2013807. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","journal-title":"Am J Med"},{"key":"4716_CR2","first-page":"25","volume":"17","author":"M Gomez-Chavarin","year":"2012","unstructured":"Gomez-Chavarin M, Roldan-Roldan G, Morales-Espinosa G, Perez-Soto G (2012) Mecanismos fisiopatol\u00f3gicos involucrados en la enfermedad de Parkinson. Arch Neurocien (Mex) 17:25\u201333","journal-title":"Arch Neurocien (Mex)"},{"key":"4716_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"4716_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/gps.4350","volume":"31","author":"GM Pontone","year":"2016","unstructured":"Pontone GM, Bakker CC, Chen S et al (2016) The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry 31:458\u2013465. https:\/\/doi.org\/10.1002\/gps.4350","journal-title":"Int J Geriatr Psychiatry"},{"key":"4716_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders JS, Ehrt U, Aarsland D, Leetjens AF (2008) A systemic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord 23:183\u2013189. https:\/\/doi.org\/10.1002\/mds.21803","journal-title":"Mov Disord"},{"key":"4716_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T et al (2019) Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 34:1464\u20131470. https:\/\/doi.org\/10.1002\/mds.27802","journal-title":"Mov Disord"},{"key":"4716_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","volume":"86","author":"S Wang","year":"2018","unstructured":"Wang S, Mao S, Xiang D, Fang C (2018) Association between depression and the subsequent risk of Parkinson\u2019s disease: a metaanalysis. Prog Neuropsychopharmacol Biol Psychiatry 86:186\u2013192. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.05.025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4716_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis M, Niccolini F (2015) Serotonin in Parkinson\u2019s disease. Behav Brain Res 277:136\u2013145. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.037","journal-title":"Behav Brain Res"},{"key":"4716_CR9","doi-asserted-by":"publisher","first-page":"e0131133","DOI":"10.1371\/journal.pone.0131133","volume":"10","author":"X Hu","year":"2015","unstructured":"Hu X, Song X, Li E et al (2015) Altered resting-state brain activity and connectivity in depressed Parkinson\u2019s disease. PLoS ONE 10:e0131133. https:\/\/doi.org\/10.1371\/journal.pone.0131133","journal-title":"PLoS ONE"},{"key":"4716_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002512-199812010-00006","volume":"12","author":"T Tom","year":"1998","unstructured":"Tom T, Cummings JL (1998) Depression in Parkinson\u2019s disease. Pharmacological characteristics and treatment. Drugs Aging 12:55\u201374. https:\/\/doi.org\/10.2165\/00002512-199812010-00006","journal-title":"Drugs Aging"},{"issue":"10","key":"4716_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/antiox9101007","volume":"9","author":"EM Prasad","year":"2020","unstructured":"Prasad EM, Hung SY (2020) Behavioral Tests in neurotoxin-induced animal models of Parkinson\u2019s disease. Antioxid (Basel) 9(10):1007. https:\/\/doi.org\/10.3390\/antiox9101007","journal-title":"Antioxid (Basel)"},{"key":"4716_CR12","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1007\/s12035-016-0147-1","volume":"54","author":"MP Cunha","year":"2017","unstructured":"Cunha MP, Pazini FL, Lieberknecht V, Budni J, Oliveira \u00c1, Rosa JM, Mancini G, Mazzardo L et al (2017) MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory\/Learning, and Striatal Neurochemical Dysfunctions. Mol Neurobiol 54:6356\u20136377. https:\/\/doi.org\/10.1007\/s12035-016-0147-1","journal-title":"Mol Neurobiol"},{"key":"4716_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pbb.2013.12.008","volume":"117","author":"M Geed","year":"2014","unstructured":"Geed M, Garabadu D, Ahmad A, Krishnamurthy S (2014) Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol Biochem Behav 117:92\u2013103. https:\/\/doi.org\/10.1016\/j.pbb.2013.12.008","journal-title":"Pharmacol Biochem Behav"},{"key":"4716_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","volume":"12","author":"X Chen","year":"2017","unstructured":"Chen X, Liu Z, Cao BB, Qiu YH, Peng YP (2017) TGF-\u03b21 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson\u2019s Disease. J Neuroimmune Pharmacol 12:433\u2013446. https:\/\/doi.org\/10.1007\/s11481-017-9732-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"4716_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2741\/S538","volume":"12","author":"GA Perez-Barron","year":"2020","unstructured":"Perez-Barron GA, Montes S, Rubio-Osornio M et al (2020) Hydroxytyrosol inhibits MAO isoforms and prevents neurotoxicity inducible by MPP+ in vivo. Front Biosci (Sch Ed) 12:25\u201337. https:\/\/doi.org\/10.2741\/S538","journal-title":"Front Biosci (Sch Ed)"},{"key":"4716_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/jn\/138.6.1074","volume":"138","author":"MJ Oliveras-L\u00f3pez","year":"2008","unstructured":"Oliveras-L\u00f3pez MJ, Berna G, Carneiro EM, de la L\u00f3pez-Garc\u00eda H, Mart\u00edn F, L\u00f3pez MC (2008) An extra-virgin olive oil rich in polyphenolic compounds has antioxidant effects in OF1 mice. J Nutr 138:1074\u20131078. https:\/\/doi.org\/10.1093\/jn\/138.6.1074","journal-title":"J Nutr"},{"key":"4716_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11418-014-0866-4","volume":"69","author":"GA P\u00e9rez-Barr\u00f3n","year":"2015","unstructured":"P\u00e9rez-Barr\u00f3n GA, Avila-Acevedo JG, Garc\u00eda-Bores AM, Montes S, Garc\u00eda-Jim\u00e9nez S, Le\u00f3n-Rivera I, Rubio-Osorio M, Monroy-Noyola A (2015) Neuroprotective effect of Buddleja cordata methanolic extrac in the 1-methyl-4-phneylpyridinium Parkinson\u2019s disease rat model. J Nat Med 69:86\u201393. https:\/\/doi.org\/10.1007\/s11418-014-0866-4","journal-title":"J Nat Med"},{"key":"4716_CR18","first-page":"1492","volume":"29","author":"S D\u2019Angelo","year":"2001","unstructured":"D\u2019Angelo S, Manna C, Migliardi V et al (2001) Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metab Dispos 29:1492\u20131498","journal-title":"Drug Metab Dispos"},{"key":"4716_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neulet.2014.07.037","volume":"579","author":"E Gallardo","year":"2014","unstructured":"Gallardo E, Palma-Valdes R, Espartero JL, Santiago M (2014) In vivo striatal measurement of hydroxytyrosol, and its metabolite (homovanillic alcohol), compared with its derivative nitrohydroxytyrosol. Neurosci Lett 579:173\u2013176. https:\/\/doi.org\/10.1016\/j.neulet.2014.07.037","journal-title":"Neurosci Lett"},{"key":"4716_CR20","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2174\/1389450117666161005150650","volume":"18","author":"S Tejada","year":"2016","unstructured":"Tejada S, Pinya S, del Mar Bibiloni M, Tur JA, Pons A, Sureda A (2016) Cardioprotective effects of the polyphenol hydroxytyrosol from olive oil. Curr Drug Targets 18:1477\u20131486. https:\/\/doi.org\/10.2174\/1389450117666161005150650","journal-title":"Curr Drug Targets"},{"key":"4716_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1080\/01635581.2017.1339818","volume":"69","author":"H Zubair","year":"2017","unstructured":"Zubair H, Bhardwaj A, Ahmad A et al (2017) Hydroxytyrosol induces apoptosis and cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells. Nutr Cancer 69:932\u2013942. https:\/\/doi.org\/10.1080\/01635581.2017.1339818","journal-title":"Nutr Cancer"},{"key":"4716_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fmicb.2019.00390","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang N, Ma Y, Wen D (2019) Hydroxytyrosol improves obesity and insulin resistance by modulating gut microbiota in high-fat diet-induced obese mice. Front Microbiol 10:390. https:\/\/doi.org\/10.3389\/fmicb.2019.00390","journal-title":"Front Microbiol"},{"key":"4716_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5650\/jos.ess15026","volume":"64","author":"F Hadrich","year":"2015","unstructured":"Hadrich F, Bouallagui Z, Junkyu H, Isoda H, Sayadi S (2015) The \u03b1-glucosidase and \u03b1-amylase enzyme inhibitory of hydroxytyrosol and oleuropein. J Oleo Sci 64:835\u2013843. https:\/\/doi.org\/10.5650\/jos.ess15026","journal-title":"J Oleo Sci"},{"key":"4716_CR24","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1021\/jf0703710","volume":"55","author":"S Schaffer","year":"2007","unstructured":"Schaffer S, Podstawa M, Visioli F, Bogani P, Muller WE, Eckert GP (2007) Hydroxytyrosol-rich olive mill wastewater protects brain cells in vitro and ex vivo. J Agric Food Chem 55:5043\u20135049. https:\/\/doi.org\/10.1021\/jf0703710","journal-title":"J Agric Food Chem"},{"key":"4716_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mnfr.201100808","volume":"56","author":"G Rodriguez-Gutierrez","year":"2012","unstructured":"Rodriguez-Gutierrez G, Duthie GG, Wood S et al (2012) Alperujo extract, hydroxytyrosol, and 3,4-dihidroxyphenylglycol are bioavailable and have antioxidant properties in vitamin E deficient rats-a proteomics and network analysis approach. Mol Nutr Food Res 56:1131\u20131147. https:\/\/doi.org\/10.1002\/mnfr.201100808","journal-title":"Mol Nutr Food Res"},{"key":"4716_CR26","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1021\/acs.jafc.5b00627","volume":"63","author":"JP De La Cruz","year":"2015","unstructured":"De La Cruz JP, Ruiz-Moreno MI, Guerrero A et al (2015) Differences in the neuroprotective effect of orally administered virgin olive oil (Olea europaea) Polyphenols tyrosol and hydroxytyrosol in rats. J Agric Food Chem 63:5957\u20135963. https:\/\/doi.org\/10.1021\/acs.jafc.5b00627","journal-title":"J Agric Food Chem"},{"key":"4716_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11745-007-3097-6","volume":"42","author":"JA Gonz\u00e1lez-Correa","year":"2007","unstructured":"Gonz\u00e1lez-Correa JA, Mu\u00f1oz-Mar\u00edn J, Arrebola MM et al (2007) Dietary virgin olive oil reduces oxidative stress and cellular damage in rat brain slices subjected to hypoxia-reoxygenation. Lipids 42:921\u2013929. https:\/\/doi.org\/10.1007\/s11745-007-3097-6","journal-title":"Lipids"},{"key":"4716_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2008.09.022","volume":"446","author":"JA Gonzalez-Correa","year":"2008","unstructured":"Gonzalez-Correa JA, Navas MD, Lopez-Villodres J, Trujillo M, Espartero JL, De La Cruz JP (2008) Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neulet 446:143\u2013146. https:\/\/doi.org\/10.1016\/j.neulet.2008.09.022","journal-title":"Neulet"},{"key":"4716_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1179\/1476830511Y.0000000005","volume":"14","author":"I Tasset","year":"2011","unstructured":"Tasset I, Pontes AJ, Hinojosa AJ, De la Torre R, Tunez I (2011) Olive oil reduces oxidative damage in a 3-nitropropionic acidinduced Huntington\u2019s disease-like rat model. Nutr Neurosci 14:106\u2013111. https:\/\/doi.org\/10.1179\/1476830511Y.0000000005","journal-title":"Nutr Neurosci"},{"key":"4716_CR30","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s11064-021-03379-x","volume":"46","author":"GA P\u00e9rez-Barr\u00f3n","year":"2021","unstructured":"P\u00e9rez-Barr\u00f3n GA, Montes S, Aguirre-Vidal Y et al (2021) Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson\u2019s Disease. Neurochem Res 46:2923\u20132935. https:\/\/doi.org\/10.1007\/s11064-021-03379-x","journal-title":"Neurochem Res"},{"key":"4716_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5607\/en.2011.20.1.1","volume":"20","author":"P Riederer","year":"2011","unstructured":"Riederer P, Laux G (2011) MAO-inhibitors in Parkinson\u2019s disease. Exp Neurobiol 20:1\u201317. https:\/\/doi.org\/10.5607\/en.2011.20.1.1","journal-title":"Exp Neurobiol"},{"key":"4716_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fphar.2016.00340","volume":"7","author":"JPM Finberg","year":"2016","unstructured":"Finberg JPM, Rabey JM (2016) Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7:340. https:\/\/doi.org\/10.3389\/fphar.2016.00340","journal-title":"Front Pharmacol"},{"key":"4716_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuro.2015.03.012","volume":"48","author":"Y Aguirre-Vidal","year":"2015","unstructured":"Aguirre-Vidal Y, Montes S, Tristan-L\u00f3pez L et al (2015) The neuroprotective effect of lovastatin on MPP(+)-induced neurotoxicity is not mediated by PON2. Neurotoxicology 48:166\u2013170. https:\/\/doi.org\/10.1016\/j.neuro.2015.03.012","journal-title":"Neurotoxicology"},{"key":"4716_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.steroids.2017.08.001","volume":"126","author":"Y Aguirre-Vidal","year":"2017","unstructured":"Aguirre-Vidal Y, Monroy-Noyola A, Anaya-Ramos L et al (2017) \u03b2-Estradiol-3-benzoate confers neuroprotection in Parkinson MPP+ rat model through inhibition of lipid peroxidation. Steroids 126:7\u201314. https:\/\/doi.org\/10.1016\/j.steroids.2017.08.001","journal-title":"Steroids"},{"key":"4716_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391. https:\/\/doi.org\/10.1016\/0014-2999(78)90118-8","journal-title":"Eur J Pharmacol"},{"key":"4716_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbr.2005.03.009","volume":"162","author":"R Rygula","year":"2005","unstructured":"Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U (2005) Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res 162:127\u2013134. https:\/\/doi.org\/10.1016\/j.bbr.2005.03.009","journal-title":"Behav Brain Res"},{"key":"4716_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.npp.1300040","volume":"28","author":"ME Keck","year":"2003","unstructured":"Keck ME, Welt T, Muller MB et al (2003) Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28:235\u2013243. https:\/\/doi.org\/10.1038\/sj.npp.1300040","journal-title":"Neuropsychopharmacology"},{"key":"4716_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","volume":"29","author":"DH Overstreet","year":"2005","unstructured":"Overstreet DH, Friedman E, Mathe AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739\u2013759. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.015","journal-title":"Neurosci Biobehav Rev"},{"key":"4716_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brainres.2010.05.097","volume":"1348","author":"SY Kim","year":"2010","unstructured":"Kim SY, Lee YJ, Kim H et al (2010) Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo (1)H-MRS study at 9.4 T. Brain Res 1348:105\u2013113. https:\/\/doi.org\/10.1016\/j.brainres.2010.05.097","journal-title":"Brain Res"},{"key":"4716_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/s0091-3057(97)00028-2","volume":"58","author":"TJ Connor","year":"1997","unstructured":"Connor TJ, Kelly JP, Leonard BE (1997) Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacol Biochem Behav 58:961\u2013967. https:\/\/doi.org\/10.1016\/s0091-3057(97)00028-2","journal-title":"Pharmacol Biochem Behav"},{"key":"4716_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.32725\/jab.2005.005","volume":"3","author":"SD Paredes","year":"2005","unstructured":"Paredes SD, Sanchez S, Rial RV, Rodriguez AB, Barriga C (2005) Changes in behaviour and in the circadian rhythms of melatonin and corticosterone in rats subjected to a forced-swimming test. J Appl Biomed 3:47\u201357","journal-title":"J Appl Biomed"},{"key":"4716_CR42","doi-asserted-by":"publisher","first-page":"00421","DOI":"10.1016\/j.psyneuen.2012.12.008","volume":"16","author":"NM Vega-Rivera","year":"2013","unstructured":"Vega-Rivera NM, Fernandez-Guasti A, Ramirez-Rodriguez G, Estrada-Camarena E (2013) Acute stress further decreases the effect of ovariectomy on immobility behavior and hippocampal cell survival in rats. Psychoneuroendocrinology 16:00421. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.12.008","journal-title":"Psychoneuroendocrinology"},{"key":"4716_CR43","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4103\/pm.pm_554_20","volume":"17","author":"G Garc\u00eda-Alonso","year":"2021","unstructured":"Garc\u00eda-Alonso G, Atzori M, Salgado R et al (2021) Antidepressant effect of Buddleja cordata methanolic extract in chronic stress mouse model. Phcog Mag 17:780\u2013785","journal-title":"Phcog Mag"},{"key":"4716_CR44","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, New York"},{"key":"4716_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1023\/a:1012283426530","volume":"31","author":"AM Bronikowski","year":"2001","unstructured":"Bronikowski AM, Carter PA, Swallow JG, Girard IA, Rhodes JS, Garland T Jr (2001) Open-field behavior of house mice selectively bred for high voluntary wheel-running. Behav Genet 31:309\u2013316. https:\/\/doi.org\/10.1023\/a:1012283426530","journal-title":"Behav Genet"},{"key":"4716_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s01664328(01)00291-1","volume":"125","author":"C Belzung","year":"2001","unstructured":"Belzung C, Griebel G (2001) Measuring normal and pathological anxiety-like behaviour in mice: A review. Behav Brain Res 125:141\u2013149. https:\/\/doi.org\/10.1016\/s01664328(01)00291-1","journal-title":"Behav Brain Res"},{"key":"4716_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00213-009-1462-2","volume":"204","author":"SL Cruz","year":"2009","unstructured":"Cruz SL, Soberanes-Ch\u00e1vez P, P\u00e1ez-Martinez N, L\u00f3pez-Rubalcava C (2009) Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs. Psychopharmacology 204:279\u2013286. https:\/\/doi.org\/10.1007\/s00213-009-1462-2","journal-title":"Psychopharmacology"},{"key":"4716_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547\u2013569. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.008","journal-title":"Neurosci Biobehav Rev"},{"key":"4716_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66\u201372. https:\/\/doi.org\/10.1007\/BF02245592","journal-title":"Psychopharmacology"},{"key":"4716_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(79)90966-1","volume":"170","author":"R Schwarcz","year":"1979","unstructured":"Schwarcz R, Fuxe K, Agnati LF, Hokfelt T, Coyle JT (1979) Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors. Brain Res 170:485\u2013495. https:\/\/doi.org\/10.1016\/0006-8993(79)90966-1","journal-title":"Brain Res"},{"key":"4716_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/a:1007680616056","volume":"26","author":"M Alcaraz-Zubeldia","year":"2021","unstructured":"Alcaraz-Zubeldia M, Rojas P, Boll C, Rios C (2021) Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice. Neurochem Res 26:61\u201366. https:\/\/doi.org\/10.1023\/a:1007680616056","journal-title":"Neurochem Res"},{"key":"4716_CR52","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/nu15071767","volume":"15","author":"L Micheli","year":"2023","unstructured":"Micheli L, Bertini L, Bonato A et al (2023) Role of Hydroxytyrosol and Oleuropein in the Prevention of Aging and Related Disorders: Focus on Neurodegeneration, Skeletal Muscle Dysfunction and Gut Microbiota. Nutrients 15:1767. https:\/\/doi.org\/10.3390\/nu15071767","journal-title":"Nutrients"},{"key":"4716_CR53","doi-asserted-by":"publisher","unstructured":"Finberg JPM, Gillman K (2011) Selective inhibitors of monoamine oxidase type B and the cheese effect. Int Rev Neurobiol. https:\/\/doi.org\/10.1016\/B978-0-12-386467-3.00009-1","DOI":"10.1016\/B978-0-12-386467-3.00009-1"},{"key":"4716_CR54","doi-asserted-by":"publisher","first-page":"111525","DOI":"10.1016\/j.biopha.2021.111525","volume":"139","author":"A Pathania","year":"2021","unstructured":"Pathania A, Kumar R, Sandhir R (2021) Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model. Biomed Pharmacother 139:111525. https:\/\/doi.org\/10.1016\/j.biopha.2021.111525","journal-title":"Biomed Pharmacother"},{"key":"4716_CR55","doi-asserted-by":"publisher","first-page":"114873","DOI":"10.1016\/j.bbr.2024.114873","volume":"28","author":"IB Bustelli","year":"2024","unstructured":"Bustelli IB, Oliveira LM, Correa-Netto NF, Stilhano RS, Caetano AL (2024) Behavioral effects of 6-hydroxydopamine-induced damage to nigro-striatal pathway and Locus coeruleus as a rodent model of Parkinson\u2019s disease. Behav Brain Res 28:114873. https:\/\/doi.org\/10.1016\/j.bbr.2024.114873","journal-title":"Behav Brain Res"},{"key":"4716_CR56","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.physbeh.2013.05.012","volume":"118","author":"OV Bogdanova","year":"2013","unstructured":"Bogdanova OV, Kanekar S, D\u2019Anci KE, Renshaw PF (2013) Factors influencing behavior in the forced swim test. Physiol Behav 118:227\u2013239. https:\/\/doi.org\/10.1016\/j.physbeh.2013.05.012","journal-title":"Physiol Behav"},{"key":"4716_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","volume":"73","author":"MJ Detke","year":"1996","unstructured":"Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43\u201346. https:\/\/doi.org\/10.1016\/0166-4328(96)00067-8","journal-title":"Behav Brain Res"},{"key":"4716_CR68","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1039\/d1fo00210d","volume":"12","author":"YT Zhao","year":"2021","unstructured":"Zhao YT, Zhang L, Yin H et al (2021) Hydroxytyrosol alleviates oxidative stress and neuroinflammation and enhances hippocampal neurotrophic signaling to improve stress-induced depressive behaviors in mice. Food Funct 12:5478\u20135487. https:\/\/doi.org\/10.1039\/d1fo00210d","journal-title":"Food Funct"},{"key":"4716_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0197-0186(85)90108-1","volume":"7","author":"BH Westerink","year":"1985","unstructured":"Westerink BH (1985) Sequence and significance of dopamine metabolism in the rat brain. Neurochem Int 7:221\u2013227. https:\/\/doi.org\/10.1016\/0197-0186(85)90108-1","journal-title":"Neurochem Int"},{"key":"4716_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0024-3205(87)90549-2","volume":"41","author":"PL Wood","year":"1978","unstructured":"Wood PL, Kim HS, Marien MR (1978) lntracerebral dialysis: direct evidence for the utility of 3-MT measurements as an index of dopamine release. Life Sci 41:1\u20135","journal-title":"Life Sci"},{"key":"4716_CR60","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/s0006-3223(01)01344-0","volume":"51","author":"WA Carlezon","year":"2002","unstructured":"Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF (2002) Antidepressant-like effects of cytidine in the forced swim test in rats. Biol Psychiatry 51:882\u2013889. https:\/\/doi.org\/10.1016\/s0006-3223(01)01344-0","journal-title":"Biol Psychiatry"},{"key":"4716_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0306-4522(80)90048-2","volume":"5","author":"CJ Pycock","year":"1980","unstructured":"Pycock CJ (1980) Turning behaviour in animals. Neuroscience 5:461\u2013514. https:\/\/doi.org\/10.1016\/0306-4522(80)90048-2","journal-title":"Neuroscience"},{"key":"4716_CR62","unstructured":"Siegel G, Alberts R, Brady S, Price D (2006) Basic neurochemistry: molecular, cellular and medical aspects. Seventh edition Chap. 12 Catecholamines"},{"key":"4716_CR63","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","volume":"84","author":"KM Sindhu","year":"2006","unstructured":"Sindhu KM, Banerjee R, Senthilkumar KS et al (2006) Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84:321\u2013329. https:\/\/doi.org\/10.1016\/j.pbb.2006.05.017","journal-title":"Pharmacol Biochem Behav"},{"key":"4716_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2022.886704","volume":"13","author":"DD Becker-Krail","year":"2022","unstructured":"Becker-Krail DD, Walker WH, Nelson RJ (2022) The Ventral Tegmental Area and Nucleus Accumbens as Circadian Oscillators: Implications for Drug Abuse and Substance Use Disorders. Front Physiol 13:1\u201317. https:\/\/doi.org\/10.3389\/fphys.2022.886704","journal-title":"Front Physiol"},{"key":"4716_CR65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3233\/JPD-202247","volume":"10","author":"S Schootemeijer","year":"2020","unstructured":"Schootemeijer S, van der Kolk NM, Ellis T et al (2020) Barriers and Motivators to Engage in Exercise for Persons with Parkinson\u2019s Disease. J Parkinsons Dis 10:1293\u20131299. https:\/\/doi.org\/10.3233\/JPD-202247","journal-title":"J Parkinsons Dis"},{"key":"4716_CR66","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/brain\/awae025","volume":"147","author":"W Gilmour","year":"2024","unstructured":"Gilmour W, Mackenzie G, Feile M et al (2024) Impaired value-based decision-making in Parkinson\u2019s disease apathy. Brain 147:1362\u20131376. https:\/\/doi.org\/10.1093\/brain\/awae025","journal-title":"Brain"},{"key":"4716_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum","volume":"14","author":"SM Palmer","year":"2015","unstructured":"Palmer SM, Crewther SG, Carey LM (2015) START Project Team. A meta-analysis of changes in brain activity in clinical depression. Front Hum Neurosci 14:1\u201319. https:\/\/doi.org\/10.3389\/fnhum","journal-title":"Front Hum Neurosci"},{"key":"4716_CR69","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1038\/s41598-020-60026-1","volume":"10","author":"AM Badr","year":"2020","unstructured":"Badr AM, Attia HA, Al-Rasheed N (2020) Oleuropein Reverses Repeated Corticosterone-Induced Depressive-Like Behavior in mice: Evidence of Modulating Effect on Biogenic Amines. Sci Rep 10:3336. https:\/\/doi.org\/10.1038\/s41598-020-60026-1","journal-title":"Sci Rep"},{"key":"4716_CR70","doi-asserted-by":"publisher","first-page":"153471","DOI":"10.1016\/j.phymed.2021.153471","volume":"83","author":"L Fan","year":"2021","unstructured":"Fan L, Peng Y, Wang J, Ma P, Zhao L, Li X (2021) Total glycosides from stems of Cistanche tubulosa alleviate depression-like behaviors: bidirectional interaction of the phytochemicals and gut microbiota. Phytomedicine 83:153471. https:\/\/doi.org\/10.1016\/j.phymed.2021.153471","journal-title":"Phytomedicine"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04716-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:36:43Z","timestamp":1777261003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4716"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04716-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental protocol was established in accordance with the ethical principles and regulations specified by the Animal Care and Use Committee of the Pharmacy Faculty at the Autonomous University of the State of Morelos.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"99"}}